Bristol-Myers Squibb today has published, before trading opened in Wall Street, its fourth-quarter 2018 results. The data show a robust growth, which in the latest quarter has yielded a sales of $6bn (+10% vs Q4 2017) with a net profit of $1.2bn.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,